Liv Pure Peptide Product: 5-Amino 1MQ

Liv Pure Peptides 5-Amino 1MQ (Nicotinamide N-methyltransferase (NNMT)) $75.00 CAS# 42464-96-0 Formula: C10H11N2+ Molecular Weight: 159.210 g/mol

5-Amino-1MQ is a chemically modified research compound engineered to inhibit the enzyme nicotinamide N-methyltransferase (NNMT), an important regulator in fat metabolism and cellular energy balance. By blocking NNMT, this molecule helps elevate NAD+ levels and activates SIRT1, a gene associated with enhanced metabolic function and longevity. Preclinical studies have indicated that 5-Amino-1MQ may support a reduction in fat cell size and promote metabolic efficiency, offering valuable insights into obesity, metabolic syndrome, and muscle preservation.

This product is intended strictly for in vitro research and laboratory applications only.

For Research Use Only – Not for Human Consumption

Sizes

Liv Pure Peptides Products: 5-Amino 1MQ 5mg

At Liv Pure Peptides, innovation meets purity. Our advanced research and rigorous quality standards deliver breakthrough peptide solutions for better health and science.

Shop Products

Products

Pages

Legal

Newsletter Signup

YOU MUST BE OVER 21 YEARS OLD TO USE THIS WEBSITE.

All products provided by Liv Pure are intended solely for in‑vitro laboratory research purposes. These materials are expressly forbidden for any form of human or animal use, ingestion, or administration, and all products are sold strictly for research, laboratory, or analytical purposes – not for human consumption.

The products offered on this platform are not formulated, designed, or intended to diagnose, cure, mitigate, treat, or prevent any diseases or medical conditions. Additionally, these statements have not been evaluated by the Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease.

All products are for Research and Development use only and are not for human consumption.

Liv Pure is a chemical supplier; LIV Pure Peptides is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor is it an outsourcing facility as defined under Section 503B of the Act.